• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.

作者信息

Morrow David A, Velazquez Eric J, DeVore Adam D, Desai Akshay S, Duffy Carol I, Ambrosy Andrew P, Gurmu Yared, McCague Kevin, Rocha Ricardo, Braunwald Eugene

机构信息

TIMI Study Group (D.A.M., Y.G., E.B.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Cardiovascular Division (D.A.M., A.S.D., E.B.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

出版信息

Circulation. 2019 May 7;139(19):2285-2288. doi: 10.1161/CIRCULATIONAHA.118.039331.

DOI:10.1161/CIRCULATIONAHA.118.039331
PMID:30955360
Abstract
摘要

相似文献

1
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.在PIONEER-HF试验中随机分配接受沙库巴曲缬沙坦或依那普利治疗的急性失代偿性心力衰竭患者的临床结局
Circulation. 2019 May 7;139(19):2285-2288. doi: 10.1161/CIRCULATIONAHA.118.039331.
2
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial.比较沙库巴曲缬沙坦与依那普利对急性心力衰竭稳定后患者 NT-proBNP 影响的 comParIson Of sacubitril/valsartaN 与 Enalapril （PIONEER-HF）试验的原理和设计。
Am Heart J. 2018 Apr;198:145-151. doi: 10.1016/j.ahj.2018.01.004. Epub 2018 Jan 10.
3
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.血管紧张素-脑啡肽酶抑制剂在急性失代偿性心力衰竭中的应用。
N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11.
4
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial.急性失代偿性心力衰竭后血管紧张素-脑啡肽酶抑制剂的启动：PIONEER-HF 试验开放标签扩展的二次分析。
JAMA Cardiol. 2020 Feb 1;5(2):202-207. doi: 10.1001/jamacardio.2019.4665.
5
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial.PIONEER-HF 试验中高危患者使用沙库巴曲缬沙坦的疗效和安全性。
Circ Heart Fail. 2021 Feb;14(2):e007034. doi: 10.1161/CIRCHEARTFAILURE.120.007034. Epub 2021 Feb 3.
6
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.PIONEER-HF 试验中急性失代偿性心力衰竭随机接受 sacubitril-valsartan 或 enalapril 治疗患者的心血管生物标志物。
Eur Heart J. 2019 Oct 21;40(40):3345-3352. doi: 10.1093/eurheartj/ehz240.
7
Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.射血分数对沙库巴曲缬沙坦（LCZ696）治疗射血分数降低的心力衰竭的疗效及预后的影响：ARNI与ACEI对心力衰竭全球死亡率和发病率影响的前瞻性比较（PARADIGM-HF）试验
Circ Heart Fail. 2016 Mar;9(3):e002744. doi: 10.1161/CIRCHEARTFAILURE.115.002744.
8
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.沙库巴曲缬沙坦对比依那普利对心衰合并糖尿病患者血糖控制的影响：来自 PARADIGM-HF 试验的事后分析。
Lancet Diabetes Endocrinol. 2017 May;5(5):333-340. doi: 10.1016/S2213-8587(17)30087-6. Epub 2017 Mar 18.
9
Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.沙库巴曲缬沙坦与依那普利治疗射血分数降低的心力衰竭患者的成本效果分析。
JAMA Cardiol. 2016 Sep 1;1(6):666-72. doi: 10.1001/jamacardio.2016.1747.
10
Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.沙库巴曲缬沙坦对心力衰竭患者身体活动和社会活动受限的影响：PARADIGM-HF 试验的二次分析。
JAMA Cardiol. 2018 Jun 1;3(6):498-505. doi: 10.1001/jamacardio.2018.0398.

引用本文的文献

1
Improving the Management of Patients with Heart Failure with Reduced Ejection Fraction in Clinical Practice: The Case for Angiotensin Receptor-Neprilysin Inhibitor.改善临床实践中射血分数降低的心力衰竭患者的管理：血管紧张素受体脑啡肽酶抑制剂的应用理由
Card Fail Rev. 2025 Jul 17;11:e16. doi: 10.15420/cfr.2024.39. eCollection 2025.
2
Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024.《2024年中国心力衰竭诊断和治疗指南》
J Geriatr Cardiol. 2025 Mar 28;22(3):277-331. doi: 10.26599/1671-5411.2025.03.002.
3
A spotlight on congestion in acute heart failure: a joint session with the Romanian Society of Cardiology (part I).
聚焦急性心力衰竭中的充血：与罗马尼亚心脏病学会的联合会议（第一部分）
Heart Fail Rev. 2025 Apr 29. doi: 10.1007/s10741-025-10515-0.
4
The Rab3 GTPase cycle modulates cardiomyocyte exocytosis and atrial natriuretic peptide release.Rab3 GTP酶循环调节心肌细胞胞吐作用及心钠素释放。
Biophys J. 2025 Jun 3;124(11):1856-1866. doi: 10.1016/j.bpj.2025.03.013. Epub 2025 Mar 20.
5
Worsening heart failure: progress, pitfalls, and perspectives.心力衰竭的恶化：进展、陷阱与展望
Heart Fail Rev. 2025 Feb 20. doi: 10.1007/s10741-025-10497-z.
6
Sacubitril/valsartan in a wide spectrum of heart failure patients (from mechanisms of action to outcomes in specific populations).沙库巴曲缬沙坦用于广泛的心力衰竭患者（从作用机制到特定人群的治疗结果）。
Heart Fail Rev. 2025 Mar;30(2):387-405. doi: 10.1007/s10741-024-10471-1. Epub 2025 Jan 7.
7
Guideline-Directed Medical Therapy After Hospitalization for Acute Heart Failure: Insights From the CONNECT-HF.急性心力衰竭住院后的指南导向性药物治疗：来自CONNECT-HF研究的见解
J Am Heart Assoc. 2024 Dec 17;13(24):e036998. doi: 10.1161/JAHA.124.036998. Epub 2024 Dec 10.
8
Perceptions of Bedside Nurses Caring for Patients with Left Ventricular Assist Devices (LVAD): A Qualitative Study.床边护士对左心室辅助装置（LVAD）患者护理的认知：一项定性研究。
SAGE Open Nurs. 2024 May 13;10:23779608241252249. doi: 10.1177/23779608241252249. eCollection 2024 Jan-Dec.
9
Clinical evidence and potential mechanisms of traditional Chinese medicine for refractory heart failure: a literature review and perspectives.中药治疗难治性心力衰竭的临床证据及潜在机制：文献综述与展望
Front Cardiovasc Med. 2024 Apr 23;11:1369642. doi: 10.3389/fcvm.2024.1369642. eCollection 2024.
10
Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.高血压伴射血分数保留的急性和慢性心力衰竭的药物治疗：最新综述。
Am J Cardiovasc Drugs. 2024 May;24(3):343-369. doi: 10.1007/s40256-024-00641-9. Epub 2024 Apr 4.